Condition

Tick Paralysis

Editors: Paritosh Prasad MD

Next Section >

Background Information

Description

  • life-threatening, acute ascending flaccid paralysis due to salivary neurotoxins secreted by ticks during a blood feed(,,,)

Also called

  • tick toxicosis

Epidemiology

Geographic distribution

  • occurs worldwide but majority of cases reported in(,)
    • United States
      • Rocky Mountain states
      • Pacific Northwest
      • Southeast
    • southwestern Canada
    • eastern coast of Australia

Incidence/Prevalence

  • rare(,,)
    • not a reportable illness so precise incidence not known and likely underestimated
    • at least 50 well-documented cases between 1946 and 2006
    • 4 cases reported in north-central Colorado in May 2006 (MMWR Morb Mortal Wkly Rep 2006 Sep 1;55(34):933)
  • Neurologic_Disordersrates in United States and Australia generally < 1 case/year (Clin Toxicol (Phila) 2015 Nov)05/31/2017 07:11:00 PM26359765 rates in United States and Australia generally < 1 case/year
    • 55 cases reported in United States between 1946 and 2014
    • 35 cases reported in Australia between 1904 and 2009
    • Reference - Clin Toxicol (Phila) 2015 Nov;53(9):874
  • most cases occur in spring and summer (peak tick season)(,,)

Likely risk factors

  • activities associated with potential tick exposure such as
    • hiking
    • camping
  • living in or traveling to endemic areas

Etiology and Pathogenesis

Causes

  • neurotoxin secreted from the salivary gland of some ticks (typically gravid female ticks)(,)
  • over 40 species of tick, both hard- and soft-bodied, reported to cause tick paralysis, including(,)
    • Dermacentor andersoni
    • Dermacentor variabilis
    • Ixodes scapularis
    • Ixodes holocyclus

Pathogenesis

  • salivary neurotoxin, holocyclotoxin, transmitted from tick to human during a blood meal(,)
    • holocyclotoxin likely acts by decreasing acetylcholine release at the neuromuscular junction
    • mechanism of action thought similar to that of botulinum toxin
    • toxin from tick in Australian variant may act differently
  • as tick feeds, toxin increases in concentration()
  • symptoms of paralysis begin about 2-7 days after bite (mean 5 days)(,)
Next Section >

Published by EBSCO Information Services. Copyright © 2025, EBSCO Information Services. All rights reserved. No part of this may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission.

EBSCO Information Services accepts no liability for advice or information given herein or errors/omissions in the text. It is merely intended as a general informational overview of the subject for the healthcare professional.

DynaMed Levels of Evidence

Quickly find and determine the quality of the evidence.

DynaMed provides easy-to-interpret Level of Evidence labels so users can quickly find and determine the quality of the best available evidence. Evidence may be labeled in one of three levels:

1Level 1 (likely reliable) Evidence
Representing research results addressing clinical outcomes and meeting an extensive set of quality criteria which minimizes bias.
There are two types of conclusions which can earn a Level 1 label: levels of evidence for conclusions derived from individual studies and levels of evidence for conclusions regarding a body of evidence.
2Level 2 (mid-level) Evidence
Representing research results addressing clinical outcomes, and using some method of scientific investigation, but not meeting the quality criteria to achieve Level 1 evidence labeling.
3Level 3 (lacking direct) Evidence
Representing reports that are not based on scientific analysis of clinical outcomes. Examples include case series, case reports, expert opinion, and conclusions extrapolated indirectly from scientific studies.

Grades of Recommendation

Guideline producers are now frequently using classification approaches for their evidence and recommendations, and these classifications are recognized and requested by guideline users. When summarizing guideline recommendations for DynaMed users, the DynaMed Editors are using the guideline-specific classifications and providing guideline classification approach when this is done.

Download the full version of Levels of Evidence